Cancer BiologybioRxivPreprint
Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma
Rebecca Rogers, Alan G. Mackay, Yura Grabovska…·Chris Jones
This study identifies a combinatorial strategy using ALK2 inhibitors and statins to target metabolic dependencies in diffuse midline glioma.
DOI 10.64898/2026.09.23.753440